{"id":304,"date":"2017-12-11T13:53:02","date_gmt":"2017-12-11T18:53:02","guid":{"rendered":"https:\/\/piramalcriticalcare.com\/australia\/?post_type=location&p=304"},"modified":"2022-10-04T19:33:35","modified_gmt":"2022-10-04T09:33:35","slug":"france","status":"publish","type":"location","link":"https:\/\/piramalcriticalcare.com\/australia\/location\/france\/","title":{"rendered":"France"},"content":{"rendered":"

Xavier Barrenechea
\n<\/strong>Country Manager
\nPhone: +33 (0)6 14 81 26 33
\nEmail: xavier.barrenechea@piramal.com<\/a><\/p>\n

The company Centre Sp\u00e9cialit\u00e9s Pharmaceutiques (CSP) is responsible for Exploitant activities on behalf of Piramal Critical Care Limited and CSP monitors pharmacovigilance and medical information: any adverse reactions related to PCC pharmaceutical specialities and medical questions relating to these products must be reported to CSP’s Pharmacovigilance Department.<\/p>\n

Telephone: +33 1 47 04 80 46 (open 24 hours a day)<\/p>\n

Mail: infomed_pv@csp-epl.com<\/a><\/p>\n

\n
\n
Proc\u00e9dure de remplissage de la Cassette Aladin 2 Desflurane Piramal GE